<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="707">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05151952</url>
  </required_header>
  <id_info>
    <org_study_id>Proton</org_study_id>
    <nct_id>NCT05151952</nct_id>
  </id_info>
  <brief_title>Proton Therapy Medical Registry</brief_title>
  <official_title>Proton Therapy Medical Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinica Universidad de Navarra, Universidad de Navarra</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinica Universidad de Navarra, Universidad de Navarra</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cl√≠nica Universidad de Navarra Proton Therapy Unit is establishing a registry to capture the&#xD;
      full radiation dosimetry delivered to the patient, baseline clinical data, and disease,&#xD;
      toxicity and quality of life outcomes. The objectives are parameters prescribed and to have&#xD;
      all patients treated at the proton therapy unit to be included in the registry to enable&#xD;
      future analysis of treatment outcomes to assist in understanding, which patients can benefit&#xD;
      from the use of protons.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Proton based radiation therapy has considerable dosimetric advantages over the standard&#xD;
      photon based external beam radiation therapy, with an increased cost. Now, the clinical&#xD;
      advantages, however, may not be identified in general, even with the improved dose&#xD;
      distributions. In a large-scale evaluation, in time of personalized/ precision medicine, the&#xD;
      impact of dosimetric benefit int clinical benefit meds registration studies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2050</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>Outcome Mesure</measure>
    <time_frame>20 years</time_frame>
    <description>Clinical outcomes will be obtains from electronic chart including: images, blood test, pathology and clinical reports</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Cancer, Therapy-Related</condition>
  <arm_group>
    <arm_group_label>Cancer patients receiving proton radiation therapy</arm_group_label>
    <description>Cancer patients receiving proton radiation therapy, Registry of cancer patients who receive proton radiation therapy to crack disease and toxicity outcomes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Other: Registry</intervention_name>
    <description>Registry of cancer patients who receive proton radiation therapy.</description>
    <arm_group_label>Cancer patients receiving proton radiation therapy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cancer patients with proton therapy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients treated at the proton center&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any other than what is supplied in the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Felipe A Calvo</last_name>
    <phone>+34913532920</phone>
    <phone_ext>7478</phone_ext>
    <email>fcalvom@unav.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>UCEC UCEC</last_name>
    <email>eecc@unav.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinica Universidad de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felipe A Calvo</last_name>
      <phone>+34948255400</phone>
      <email>fcalvom@unav.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Universidad de Navarra</name>
      <address>
        <city>Madrid</city>
        <zip>28027</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felipe A Calvo</last_name>
      <phone>+34913531920</phone>
      <phone_ext>7478</phone_ext>
      <email>fcalvom@uanv.es</email>
    </contact>
    <investigator>
      <last_name>Jose Javier Aristu</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Felipe A Calvo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 11, 2021</study_first_submitted>
  <study_first_submitted_qc>November 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>November 25, 2021</last_update_submitted>
  <last_update_submitted_qc>November 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Proton therapy Additional relevant MeSH terms: Neoplasms, Secondary Primary Neoplasms, Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms, Second Primary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

